Abpro
Woburn, US
Biotech
Founders & leadership
EC
Eugene ChanDirector
BH
Benjamin HaDirector
IC
Ian ChanExecutive Officer, Director
SQ
Shengxin QinDirector
TW
Thomas WengDirector
KC
Kevin ComerfordExecutive Officer
Reported raises · per SEC filings
Form D private placements$2MraisedApr 2022 · 1 investors · Biotechnology
Rule 506(b)$18MraisedJan 2020 · 1 investors · Biotechnology
Rule 506(b)$10MraisedApr 2017 · 1 investors · Biotechnology
Rule 506(b)$12.4MraisedMar 2016 · 7 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.